Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NovelStem InternationalNSTM Market Cap is $0.57 Mil as of Aug. 01, 2026. The stock has 2 warning signs investors should review. Among 217 Medical Diagnostics & Research companies, NovelStem International ranks worse than 98.62% on this metric.
NovelStem International's quarterly market cap
declined
from Sep. 2025 ($1.30 Mil) to Dec. 2025 ($0.42 Mil) but then
increased
from Dec. 2025 ($0.42 Mil) to Mar. 2026 ($0.49 Mil).
NovelStem International's annual market cap
declined
from Dec. 2023 ($2.95 Mil) to Dec. 2024 ($0.37 Mil) but then
increased
from Dec. 2024 ($0.37 Mil) to Dec. 2025 ($0.42 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NovelStem International's Enterprise Value for Today is $2.41 Mil.
NovelStem International (OTCPK:NSTM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
NovelStem International Market Cap Related Terms
NovelStem International Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, NovelStem International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NovelStem International Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, NovelStem International's Market Cap distribution charts can be found below:
* The bar in red indicates where NovelStem International's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
NovelStem International's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NovelStem International (NSTM) has a Market Cap of $0.57 Mil as of Aug. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NovelStem International and its competitors. According to the industry distribution chart, NovelStem International ranks #214 out of 217 companies in the Medical Diagnostics & Research industry, placing it in the top 98.6%.
Is NovelStem International's Market Cap too high?
NovelStem International's current Market Cap is $0.57 Mil. The Medical Diagnostics & Research industry median Market Cap is 58.86. NovelStem International's value of $0.57 Mil is 99% below this industry median. Based on the distribution chart, NovelStem International ranks #214 out of 217 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does NovelStem International's Market Cap compare to NOTVQ and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, NovelStem International ranks #214 out of 217 companies for Market Cap. This places NovelStem International in the lower half of its industry. The industry median Market Cap is 58.86. NovelStem International's value of $0.57 Mil is 99% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 58.86, based on 217 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NovelStem International's current Market Cap of $0.57 Mil is 99% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NovelStem International and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 58.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NovelStem International's current Market Cap is $0.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovelStem International stock overvalued right now?
NovelStem International (NSTM) has a current Market Cap of $0.57 Mil. The current Market Cap is $0.57 Mil and 99% below the Medical Diagnostics & Research industry median of 58.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For NovelStem International (NSTM), the current Market Cap is $0.57 Mil as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NovelStem International Corp is a holding company. Through its subsidiaries, the company is engaged in the development and commercialization of diagnostic technology that can predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. The company also has an interest in a book publishing franchise.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSTM has been successfully added to your 
